Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
73.00    -0.50 (-0.68%)
Bid:
72.00
Ask:
74.00
Spread: 2.00 (2.778%)
Market Cap: £342.04m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Sch 1 - Readybuy PLC

21 Jul 2006 10:15

AIM21 July 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Readybuy plc COMPANY ADDRESS:Television House, 10-12 Mount Street, Manchester COMPANY POSTCODE:M2 5NT COUNTRY OF INCORPORATION:England and Wales COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:Since the Readybuy group's trading activities were terminated in July 2005, the directors of Readybuy have beenexploring the future options available to the Company. The Company's investing strategy is to acquire a companyinvolved in developing enabling technologies, particularly in the defence and bio-chemistry sectors. The Boardbelieves that the proposed acquisition of Avacta meets this investment strategy. Avacta was spun-out from the University of Leeds in January 2004 by its current management team as a biophysicscompany, with the aim of combining the disciplines of physics and biology to develop innovative technologies toaddress needs in the homeland security, pharmaceutical and clinical diagnostic markets. Avacta has two core activities: the development of detection technology platforms designed to meet the needs ofits target markets; and the provision of analytical services relating to the chemical and physical analysis ofmaterials to a range of companies, principally in the pharmaceutical, healthcare and personal care sectors. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):644,857,446 ordinary shares of 0.1p each on First Admission 24,469,898 ordinary shares of 0.1p each on Second AdmissionCAPITAL TO BE RAISED ON ADMISSION:£1,012,500 before expenses, by means of a placing of 45,000,000 ordinary shares of 0.1p each at 2.25p per share FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Directors: Daron Ross Lee (non-executive Chairman) Professor David Alastair Maclaughlin Smith (non-executive director and proposed Chief Executive followingAdmission) Proposed Directors: Dr. Gwynfor Owen Humphreys (proposed non-executive Chairman)Dr. Simon Webster (proposed Chief Scientific Officer)Dr. Kurt Justin Baldwin (proposed Chief Technology Officer)Timothy James Sykes (proposed Chief Financial Officer and proposed Company Secretary)Professor Anthony William Robards (proposed non-executive director)Alan John Aubrey (propose non-executive director) PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION:Before: Robert Quested (29.76%)Christopher Potts (16.96%)Stephen James (16.09%)Robert Quested, Christopher Potts and Stephen James are also interested in warrants to subscribe for 18,500,000;10,500,000; and 10,000,000 Ordinary Shares respectively. On Admission: Robert Quested (8.93%)Christopher Potts (3.15%)Stephen James (2.99%) The members of the Existing Concert Party, as at the date of this document, together hold 83.71% of the issuedshare capital of the Company, and will, immediately following the Placing and Admission hold 19.84 % thereof.The members of the New Concert Party (being the vendors of Avacta), as at the date of this document, togetherhold 0.96% of the issued share capital of the Company, and will, immediately following the Placing and Admissionhold 74.88% thereof. NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:None ANTICIPATED ACCOUNTING REFERENCE DATE:30 April EXPECTED ADMISSION DATE:8 August 2006 (First Admission)9 August 2006 (Second Admission) NAME AND ADDRESS OF NOMINATED ADVISER:WH Ireland Limited11 St James's SquareManchesterM2 6WH NAME AND ADDRESS OF BROKER:WH Ireland Limited11 St James's SquareManchesterM2 6WH DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENTTHAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:Copies of the admission document containing full details about the applicant and the admission of its securitieswill be available free of charge to the public until at least one month after admission at the offices of:- WH Ireland Limited11 St James's SquareManchesterM2 6WH DATE OF NOTIFICATION:21 July 2006 NEW/ UPDATE (see note):New This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Apr 20117:00 amRNSInterim Results
12th Apr 201112:42 pmRNSIssue of Equity
29th Mar 20117:00 amRNSExclusive distribution agreement with DKSH Japan
28th Mar 20117:00 amRNSAdditional Listing
22nd Mar 201110:11 amRNSAdditional Listing
17th Mar 20117:00 amRNSDirectorate Change
4th Mar 20117:00 amRNSTrading Statement
23rd Feb 20117:00 amRNSRe Agreement
3rd Feb 20117:00 amRNSRe Agreement
3rd Feb 20117:00 amRNSIssue of Equity
27th Jan 20114:55 pmRNSHolding(s) in Company
27th Jan 20117:00 amRNSDirector/PDMR Shareholding
26th Jan 20117:00 amRNSIssue of Equity
25th Jan 201111:57 amRNSHolding(s) in Company
21st Jan 20113:47 pmRNSAGM Result and Placing
12th Jan 20117:00 amPRNPlacing, Issue of Equity and related party transaction
5th Jan 201111:59 amPRNExercise of Warrants
4th Jan 20116:28 pmPRNHolding(s) in Company
4th Jan 20117:00 amRNSProduct Sale
31st Dec 20109:57 amPRNHolding(s) in Company
30th Dec 20102:36 pmPRNHolding(s) in Company
25th Nov 20107:00 amRNSProduct Launch
15th Nov 20107:00 amPRNGrant of Options to Directors
3rd Nov 20107:00 amRNSFinal Results
27th Oct 20107:00 amRNSProduct Sale
27th Oct 20107:00 amRNSProduct Sale
26th Oct 20107:00 amPRNIssue of Equity
14th Oct 20107:00 amRNSRe Agreement
20th Sep 20107:00 amPRNLicensing Agreement
7th Sep 20105:08 pmPRNHolding(s) in Company
6th Sep 20107:00 amPRNDistribution Agreement
6th Aug 20109:55 amPRNDirector/PDMR Shareholding
29th Jul 20107:00 amPRNIssue of Equity
6th Jul 20107:00 amPRNIssue of Equity
1st Jun 20107:00 amPRNChange of Adviser
30th Apr 20107:00 amPRNHalf-yearly Report
8th Mar 20107:00 amRNSNotice of Results and Trading Update
3rd Mar 20107:00 amRNSAcquisition
22nd Feb 20102:42 pmRNSDirector/PDMR Shareholding
25th Jan 20107:00 amRNSResult of AGM
21st Dec 200910:35 amRNSIssue of Equity
26th Nov 20097:03 amRNSPreliminary Results
26th Nov 20097:00 amRNSIssue of Equity
4th Nov 20097:00 amPRNNotice of Results
21st Oct 20097:00 amPRNPlacing and Issue of Equity
6th Oct 20097:00 amRNSOptim - Second Order
28th Sep 20097:00 amPRNRe Agreement
16th Sep 20093:03 pmRNSHolding(s) in Company
11th Sep 20094:26 pmRNSHolding(s) in Company
11th Sep 20093:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.